Takimoto, C.H. and Beeram, M. (2008) Microtubule stabilizing agents in clinical oncology in The Role of Microtubules in Cell Biology, Neurobiology, and Oncology (Fojo, T. Ed.). Humana Press, Totowa, NJ, pp. 395–419.
2Herbst, R.S. and Khuri, F.R. (2003) Mode of action of docetaxel - a basis for combination with novel anticancer agents. Cancer Treat. Rev., 29, 407–415.
3Clarke, S.J. and Rivory, L.P. (1999) Clinical pharmacokinetics of docetaxel. Clin. Pharmacokinet., 36, 99–114.
4Kenmotsu, H. and Tanigawara, Y. (2015) Pharmacokinetics, dynamics and toxicity of docetaxel: why the Japanese dose differs from the Western dose. Cancer Sci., 106, 497–504.
5Yanasarn, N., Sloat, B.R. and Cui, Z. (2009) Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel. Int. J. Pharm., 379, 174–180.
6Kim, G.H., Lee, J.Y., Kang, Y.M., Kang, K.N., Kim, E.S., Kim, D.Y., Kim, J.H. and Kim, M.S. (2011) Preparation and characterization of self-emulsified docetaxel. J. Nanomater., 2011, 6.
7Du, W., Hong, L., Yao, T., Yang, X., He, Q., Yang, B. and Hu, Y. (2007) Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid. Bioorg. Med. Chem., 15, 6323–6330.
8Naik, S., Patel, D., Surti, N. and Misra, A. (2010) Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology. J. Supercrit. Fluids, 54, 110–119.
9Liang, G., Jia-Bi, Z., Fei, X. and Bin, N. (2010) Preparation, characterization and pharmacokinetics of N-palmitoyl chitosan anchored docetaxel liposomes. J. Pharm. Pharmacol., 59, 661–667.
10Lee, S.-W., Yun, M.-H., Jeong, S.W., In, C.-H., Kim, J.-Y., Seo, M.-H., Pai, C.-M. and Kim, S.-O. (2011) Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. J. Control. Release, 155, 262–271.
11Lee, M.Y., Song, H., Nakai, J., Ohkura, M., Kotlikoff, M.I., Kinsey, S.P., Golovina, V.A. and Blaustein, M.P. (2006) Local subplasma membrane Ca2+ signals detected by a tethered Ca2+ sensor. Proc. Natl. Acad. Sci. U.S.A., 103, 13232–13237.
12Oh, S.-J., Kim, H., Liu, Y., Han, H.-K., Kwon, K., Chang, K.-H., Park, K., Kim, Y., Shim, K., An, S.S.A. and Lee, M.-Y. (2014) Incompatibility of silver nanoparticles with lactate dehydrogenase leakage assay for cellular viability test is attributed to protein binding and reactive oxygen species generation. Toxicol. Lett., 225, 422–432.
13Liu, Y., Park, J.-M., Chang, K.-H., Huh, H.J., Lee, K. and Lee, M.-Y. (2016) AMP-activated protein kinase mediates the antiplatelet effects of the thiazolidinediones rosiglitazone and pioglitazone. Mol. Pharmacol., 89, 313–321.
14Park, J.-M., Chang, K.-H., Park, K.-H., Choi, S.-J., Lee, K., Lee, J.-Y., Satoh, M., Song, S.-Y. and Lee, M.-Y. (2016) Differential effects between cigarette total particulate matter and cigarette smoke extract on blood and blood vessel. Toxicol. Res., 32, 353–358.
15Park, J.-M., Lee, J.-H., Na, C.-S., Lee, D., Lee, J.-Y., Satoh, M. and Lee, M.-Y. (2016) Heartwood extract of Rhus verniciflua Stokes and its active constituent fisetin attenuate vasoconstriction through calcium-dependent mechanism in rat aorta. Biosci. Biotechnol. Biochem., 80, 493–500.
16Chang, K.H., Park, J.M., Lee, C.H., Kim, B., Choi, K.C., Choi, S.J., Lee, K. and Lee, M.Y. (2017) NADPH oxidase (NOX) 1 mediates cigarette smoke-induced superoxide generation in rat vascular smooth muscle cells. Toxicol. In Vitro, 38, 49–58.
17Ojima, I., Lichtenthal, B., Lee, S., Wang, C. and Wang, X. (2016) Taxane anticancer agents: a patent perspective. Expert Opin. Ther. Pat., 26, 1–20.
18Huang, X.-X., Zhou, C.-L., Wang, H., Chen, C., Yu, S.-Q., Xu, Q., Zhu, Y.-Y. and Ren, Y. (2011) Pharmacokinetics, efficacy, and safety evaluation of docetaxel/hydroxypropyl-sulfobutyl-β-cyclodextrin inclusion complex. AAPS Pharm-SciTech, 12, 665–672.
19Wang, Y.B., Wang, J.C., Meng, M., Zhang, H. and Zhang, Q. (2010) Preparation and evaluation of docetaxel-loaded albumin nanoparticles for intravenous administration. J. Chin. Pharm. Sci., 19, 214–222.
20Engels, F.K., Mathot, R.A.A. and Verweij, J. (2007) Alternative drug formulations of docetaxel: a review. Anticancer Drugs, 18, 95–103.
21Elm’hadi, C., Tanz, R., Khmamouche, M.R., Toreis, M., Mahfoud, T., Slimani, K.A., Errihani, H. and Ichou, M. (2016) Toxicities of docetaxel: original drug versus generics-a comparative study about 81 cases. SpringerPlus, 5, 732.
22Fu, P.P., Xia, Q., Hwang, H.-M., Ray, P.C. and Yu, H. (2014) Mechanisms of nanotoxicity: generation of reactive oxygen species. J. Food Drug Anal., 22, 64–75.
留言 (0)